CZP is a PEGylated Fab fragment of a humanized anti-TNF antibody approved for the treatment of CD, RA, Ps, and nonradiographic axial spondyloarthritis (nr-axSpA) [44,45]. The gene discussed is TNF; the disease is rheumatoid arthritis.